New data strengthen profile for Pharmacyclics' novel blood cancer drug
13 December 2011
Alex Shimmings
Please Login to read the full article.
13 December 2011
Alex Shimmings
alex.shimmings@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Pharmacyclics raises $57M to advance tyrosine kinase inhibitor for blood cancers
- Amgen reveals latest updated data for BiTE drug in acute lymphoblastic leukaemia
- One down, two to go: startup Tolero licenses one of MannKind's cancer programmes
- Pfizer's two cancer candidates accepted for EMA review
FEATURES
Other Informa Features
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
